Combined short-pulsed Nd:YAG laser therapy with intralesional triamcinolone injection for hypertrophic scar and keloid treatment
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20261927Keywords:
Keloid, Hypertrophic scar, Nd-YAG laser, Triamcinolone, 5-Fluorouracil, POSASAbstract
Background: Hypertrophic scars and keloids are difficult to treat and are associated with pain, pruritus, functional impairment, and cosmetic burden. This study evaluated the effectiveness of combining short-pulsed 1064 nm Nd:YAG laser therapy with intralesional triamcinolone injection compared with conventional treatment approaches.
Methods: Between October 2016 and March 2021, 52 patients with hypertrophic scars or keloids were treated at Hautärzte Köln Mülheim, Buchheimer Str. 53-55, 51063 Cologne, Germany, a private dermatology practice specializing in dermatology and laser medicine. Patients were classified into three treatment cohorts according to the treatment received: triamcinolone acetonide (TAC) monotherapy (n=13), TAC plus 5-fluorouracil (5-FU) (n=13), and combination therapy with short-pulsed 1064 nm Nd:YAG laser plus intralesional TAC in the same session (n=26). Laser treatment was performed in Genesis mode using a pulse duration of 0.33 ms, fluence of 4.4 J/cm², and repetition rate of 6 to 8 Hz. Spot size from 4 to 8 mm was adjusted according to scar thickness. Outcomes were assessed using the patient and observer scar assessment scale (POSAS) at baseline and at 3 and 12 months after treatment.
Results: The combination group required fewer treatment sessions than the TAC+ 5-FU group and the TAC monotherapy group (mean 7.2 versus 10.6 and 12.2 sessions, respectively). At 12 months, the combination group showed significantly better POSAS scores than TAC monotherapy on both the patient scale (20.65 versus 30.08, p=0.006) and observer scale (17.81 versus 28.15, p=0.001). No dropouts or serious adverse events occurred.
Conclusions: Short-pulsed 1064 nm Nd:YAG laser combined with intralesional triamcinolone is an effective, safe, and time-efficient treatment for hypertrophic scars and keloids, with superior outcomes compared with steroid monotherapy.
References
Naik PP. Novel targets and therapies for keloid. Clin Exp Dermatol. 2022;47(3):507-15. DOI: https://doi.org/10.1111/ced.14920
Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):606. DOI: https://doi.org/10.3390/ijms18030606
Shin J, Cho JT, Park SI, Jung SN. Combination therapy using non-ablative fractional laser and intralesional triamcinolone injection for hypertrophic scars and keloids treatment. Int Wound J. 2019;16(6):1450-6. DOI: https://doi.org/10.1111/iwj.13213
Ogawa R. Long-pulsed 1064 nm Nd:YAG laser treatment for keloids and hypertrophic scars. In: Téot L, Mustoe TA, Middelkoop E, Gauglitz GG, editors. Textbook on scar management: state of the art management and emerging technologies. Cham: Springer; 2020:271-8. DOI: https://doi.org/10.1007/978-3-030-44766-3_32
Draaijers LJ, Tempelman FRH, Botman YAM, Tuinebreijer WE, Middelkoop E, Kreis RW, et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg. 2004;113(7):1960-5. DOI: https://doi.org/10.1097/01.PRS.0000122207.28773.56
Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124(6):869-71. DOI: https://doi.org/10.1001/archderm.1988.01670060015008
Ansari MA, Erfanzadeh M, Mohajerani E. Mechanisms of laser-tissue interaction: II. Tissue thermal properties. J Lasers Med Sci. 2013;4(3):99-106.
Dams SD. The effect of heat shocks in skin rejuvenation. Eindhoven: Technische Universiteit Eindhoven. PhD thesis. 2010.
Jia X, Feng Y. Energy-based skin rejuvenation: a review of mechanisms and thermal effects. J Cosmet Dermatol. 2025;24(2):e16657. DOI: https://doi.org/10.1111/jocd.16657
Srivastava S, Patil A, Prakash C, Kumari H. Comparison of intralesional triamcinolone acetonide, 5-fluorouracil, and their combination in treatment of keloids. World J Plast Surg. 2018;7(2):212-9.
Suthamjariya K, Farinelli WA, Koh W, Anderson RR. Mechanisms of microvascular response to laser pulses. J Invest Dermatol. 2004;122(2):518-25. DOI: https://doi.org/10.1046/j.0022-202X.2004.22241.x
Srivastava S, Patil AN, Prakash C, Kumari H. Comparison of intralesional triamcinolone acetonide, 5-fluorouracil, and their combination for the treatment of keloids. Adv Wound Care (New Rochelle). 2017;6(11):393-400. DOI: https://doi.org/10.1089/wound.2017.0741
Reddy CVPK, Surekha A. A comparative study on treatment of keloid with triamcinolone versus 5-fluorouracil and triamcinolone. Int Surg J. 2020;7(5):1373-7. DOI: https://doi.org/10.18203/2349-2902.isj20201518
Walsh LA, Wu E, Pontes D, Kwan KR, Poondru S, Miller CH, et al. Keloid treatments: an evidence-based systematic review of recent advances. Syst Rev. 2023;12(1):42. DOI: https://doi.org/10.1186/s13643-023-02192-7
Park JH, Jeong JW, Park JU. Efficacy of Nd:YAG laser and intralesional triamcinolone injection combination therapy in the postoperative management of keloids. Aesthetic Plast Surg. 2025;49(3):722-31. DOI: https://doi.org/10.1007/s00266-024-04433-z
Downloads
Published
How to Cite
Issue
Section
